PTIX – protagenic therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Atrinsic (NASDAQ:PTIX) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.
Atrinsic (NASDAQ:PTIX) is now covered by analysts at Weiss Ratings. They set a "sell (e)" rating on the stock.
Atrinsic (NASDAQ:PTIX) was upgraded by analysts at Wall Street Zen f
Form DEF 14A Protagenic Therapeutics, For: Dec 05
Form 10-Q Protagenic Therapeutics, For: Sep 30
Form 8-K Protagenic Therapeutics, For: Nov 20
Form NT 10-Q Protagenic Therapeutics, For: Sep 30
Form 8-K Protagenic Therapeutics, For: Nov 03
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.